Miriam C. Poirier - Concepedia

Author

Miriam C. Poirier

Also Known As

Carter, Meghan M., M C Poirier, M C Poirier,, M POIRIER, M Poirier, M. C. Poirier, M. Poirier, M.C. Poirier, MIRIAM C. POIRIER, Miriam C Poirier

279

Publications

9.2K

Citations

H-Index

196

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Center for Toxicological Research Science Applications International Corporation (United States)

About

Miriam C. Poirier is an author at National Cancer Institute specializing in medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	105	4.7K
2	Public Health	16	20	801
3	Natural Sciences	13	19	600
4	Engineering	5	5	316
5	Health Sciences	3	3	42

Miriam C. Poirier

157

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and Monkeys Ofelia A. Olivero, Stuart H. Yuspa, Miriam C. Poirier, JNCI Journal of the National Cancer Institute	1997	226
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. E Reed, Robert F. Ozols, Robert E. Tarone, Proceedings of the National Academy of Sciences Hematological MalignancyAdduct MeasurementsAdduct FormationDisease ResponseMedicine	1987	220
Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected Mothers Miriam C. Poirier, Rao L. Divi, Lena Al‐Harthi, JAIDS Journal of Acquired Immune Deficiency Syndromes Long-term Mitochondrial ToxicityPediatricsMaternal HealthMitochondrial MedicineHiv	2003	184
A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene — DNA adducts in animal and human tissues by immunoassays Frederica P. Perera, Miriam C. Poirier, Stuart H. Yuspa, Carcinogenesis EngineeringImmunotoxicologyMolecular Cancer EpidemiologyPathologyLung Tissue	1982	167
Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. E Reed, Stuart H. Yuspa, Leonard A. Zwelling, Journal of Clinical Investigation GynecologyPathology-Dna-intrastrand AdductsTumor BiologyOvarian Cancer	1986	157
Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Miriam C. Poirier, Regina M. Santella, I. Bernard Weinstein, PubMed Immunocytochemical TechniqueMajor AdductLaboratory ImmunologyImmunophenotypingOrganic Chemistry	1980	147
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption Daehee Kang, Nathaniel Rothman, Miriam C. Poirier, Carcinogenesis	1995	140
p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Carlos L. Arteaga, Angela R. Winnier, Miriam C. Poirier, PubMed Tumor BiologyTab 250MedicineReceptor Tyrosine KinasePharmacology	1994	128
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero Ofelia A. Olivero, Gene M. Shearer, Claire Chougnet, AIDS	1999	122
Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. David W. Rowe, Jay R. Shapiro, Miriam C. Poirier, Journal of Clinical Investigation Bone RepairPathologyOsteogenesisOsteoporosisOrthopaedic Surgery	1985	112

Page 1